A top official with the U.S. Department of Health and Human Services this week called on the Drug Enforcement Administration to reclassify marijuana under...
The country’s legal marijuana business — a rarity in Asia — is struggling with oversupply, illegal imports and regulatory ambiguity. Investors are piling in...
Cannabinoids (CBDs) are gaining popularity in both the skin care industry and the dermatology drug market and are becoming increasingly available to physicians and...